Function
Locations
7-alpha-hydroxylate cholesterol (classic-pathway commitment, rate-limiting).
Bile acids are the amphipathic end-products of hepatic cholesterol catabolism; their synthesis is the major route of cholesterol elimination and produces the detergents that emulsify dietary lipids. Two pathways convert cholesterol to the primary bile acids cholic acid (CA) and chenodeoxycholic acid (CDCA). In the CLASSIC (neutral) pathway, the rate-limiting ER cytochrome P450 CYP7A1 7-alpha-hydroxylates cholesterol; HSD3B7 then oxidises/isomerises the 3-beta-hydroxy-Delta5 sterol to a 3-oxo-Delta4 intermediate; the branch-point enzyme CYP8B1 (sterol 12-alpha-hydroxylase) 12-alpha-hydroxylates that intermediate to commit flux toward CA (its absence yields CDCA), setting the CA:CDCA ratio; AKR1D1 (Delta4-3-oxosteroid 5-beta-reductase) and AKR1C4 (3-alpha-hydroxysteroid dehydrogenase) then reduce the A/B-ring to the 5-beta-3-alpha-hydroxy configuration. In the ALTERNATIVE (acidic) pathway, the sterol side chain is oxidised first: the mitochondrial CYP27A1 (sterol 27-hydroxylase), the ER di-iron enzyme CH25H (25-hydroxylase) and the neuron-specific CYP46A1 (24-hydroxylase, the main route of brain cholesterol elimination) generate oxysterols, which the oxysterol 7-alpha-hydroxylases CYP7B1 (25-/27-OHC) and CYP39A1 (24S-OHC) route into bile-acid synthesis. Both pathways converge on side-chain shortening: CYP27A1 oxidises the C27 side chain to a C27 acid, AMACR racemises the (25R)- to the (25S)-acyl-CoA, and peroxisomal beta-oxidation (ACOX2 -> the D-bifunctional protein -> the SCPx thiolase, curated in the peroxisomal module) removes a propionyl unit to give the C24 bile-acyl-CoA. Finally the bile acid is activated by the CoA ligase SLC27A5 (BACS) and conjugated to glycine or taurine by BAAT. Inherited defects across the pathway cause bile-acid synthesis disorders: CYP7B1 (oxysterol 7-alpha-hydroxylase deficiency / SPG5), HSD3B7, AKR1D1, ACOX2, BAAT and SLC27A5 deficiencies, and CYP27A1 causes cerebrotendinous xanthomatosis.
All recommended fields populated.
✗ none found
No MODULE:bile_acid_biosynthesis deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
12 complete review(s) · 0 with deep research · 0 missing review · 13 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| AKR1C4 P17516 | ✓ | ✓ | ✗ |
| AKR1D1 P51857 | ✓ | ✓ | ✗ |
| AMACR Q9UHK6 | ✓ | 38/39 | ✗ |
| BAAT Q14032 | ✓ | ✓ | ✗ |
| CH25H O95992 | ✓ | ✓ | ✗ |
| CYP27A1 Q02318 | ✓ | ✓ | ✗ |
| CYP39A1 Q9NYL5 | ✓ | ✓ | ✗ |
| CYP46A1 Q9Y6A2 | ✓ | ✓ | ✗ |
| CYP7A1 P22680 | ✓ | ✓ | ✗ |
| CYP7B1 O75881 | ✓ | ✓ | ✗ |
| CYP8B1 Q9UNU6 | ✓ | ✓ | ✗ |
| HSD3B7 Q9H2F3 | ✓ | ✓ | ✗ |
| SLC27A5 Q9Y2P5 | ✓ | ✓ | ✗ |
Bile-acid biosynthesis (GO:0006699 + GO:0008203), grounded to fifteen completed human gene reviews (ten reviewed/merged earlier: CYP7A1/CYP27A1/CYP7B1/HSD3B7/AKR1D1/AMACR/ACOX2/SCP2/BAAT/SLC27A5; five new here: CYP8B1/AKR1C4/CH25H/CYP39A1/CYP46A1). CLASSIC pathway: CYP7A1 (P22680 PTHR24304 GO:0008123, rate-limiting) -> HSD3B7 (Q9H2F3 PTHR10366 GO:0003854) -> CYP8B1 (Q9UNU6 PTHR24306 GO:0008397, 12a-hydroxylase = cholic-acid branch; NB GO:0047749 obsolete) -> AKR1D1 (P51857 GO:0047787 5b-reductase) -> AKR1C4 (P17516 GO:0140169 3a-HSD; both PTHR11732). ALTERNATIVE (acidic) pathway: oxysterols from CYP27A1 (Q02318 PTHR24279 GO:0047748, mito 27-hydroxylase; CTX), CH25H (O95992 PTHR11863 GO:0001567 DI-IRON 25-hydroxylase) and neuronal CYP46A1 (Q9Y6A2 PTHR24293 GO:0033781 24-hydroxylase) -> 7a-hydroxylated by CYP7B1 (O75881 GO:0008396; SPG5) and CYP39A1 (Q9NYL5 GO:0033782; both P450-family-7 PTHR24304). SHARED side-chain shortening: CYP27A1 side-chain oxidation -> AMACR (Q9UHK6 PTHR48228 GO:0008111 racemase) -> peroxisomal beta-oxidation ACOX2 (Q99424 GO:0003997) + SCPx/SCP2 (P22307 GO:0050632) [peroxisomal-beta-oxidation module] -> C24 bile-acyl-CoA. CONJUGATION: SLC27A5 (Q9Y2P5 PTHR43107 GO:0047747 BACS) -> BAAT (Q14032 PTHR10824 GO:0047963 gly/tau conjugation). GO term ids/labels verified against the local go.db. Cholesterol is the substrate; the bile acids feed the enterohepatic bile-salt transport system (SLC10A1/ABCB11, separate). Disorders: CYP27A1 CTX, CYP7B1 SPG5, HSD3B7/AKR1D1/ACOX2/BAAT/SLC27A5 bile-acid-synthesis defects/cholestasis.
7-alpha-hydroxylate cholesterol (classic-pathway commitment, rate-limiting).
27-hydroxylate cholesterol / oxidise side chain (alternative pathway).
25-hydroxylate cholesterol (oxysterol; alternative pathway + immune signalling).
24-hydroxylate cholesterol (neuronal cholesterol elimination -> alt pathway).
7-alpha-hydroxylate 25-/27-oxysterols (alternative pathway).
7-alpha-hydroxylate 24S-oxysterol (alternative pathway).
Oxidise/isomerise 3-beta-hydroxy-Delta5 to 3-oxo-Delta4 intermediate.
12-alpha-hydroxylate the 3-oxo-Delta4 intermediate (cholic-acid branch).
Reduce the Delta4 double bond (5-beta configuration).
Reduce the 3-oxo group to 3-alpha-hydroxy (bile-acid ring completion).
CYP27A1 (GO:0047748) oxidises the C27 side chain to a bile-acyl-CoA; AMACR (GO:0008111) racemises it; ACOX2 (Q99424, GO:0003997) then the D-bifunctional protein and SCPx thiolase (SCP2, P22307, GO:0050632; curated in the peroxisomal beta-oxidation module) remove a propionyl unit to give the C24 bile-acyl-CoA.
Activate the bile acid to bile-acyl-CoA (ATP/CoA).
Conjugate the bile-acyl-CoA to glycine/taurine (final step).